Mallinckrodt PLC | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
276
708
366
281
1,281
349
Total Accounts Receivable
463
628
571
509
606
640
Inventories
403
397
262
336
340
322
Other Current Assets
243
339
647
381
58
117
Total Current Assets
1,385
2,071
1,846
1,507
2,285
1,427
Net Property, Plant & Equipment
997
949
793
844
967
982
Total Investments and Advances
24
70
66
19
18
-
Intangible Assets
954
9,514
13,316
12,888
11,858
8,283
Other Assets
189
237
376
217
137
165
Total Assets
3,557
12,865
16,404
15,499
15,281
10,877
ST Debt & Current Portion LT Debt
2
21
22
256
314
Accounts Payable
200
213
117
110
113
Income Tax Payable
53
26
21
112
17
Other Current Liabilities
345
645
770
757
606
Total Current Liabilities
600
905
929
1,235
1,050
Long-Term Debt
918
3,952
6,474
5,789
6,421
Provision for Risks & Charges
198
220
188
218
140
Deferred Taxes
303
2,375
3,111
2,557
673
Other Liabilities
274
432
384
405
458
Total Liabilities
2,301
7,907
11,093
10,228
8,759
Common Equity (Total)
1,256
4,958
5,311
5,271
6,522
Total Shareholders' Equity
1,256
4,958
5,311
5,271
6,522
Total Equity
1,256
4,958
5,311
5,271
6,522
Liabilities & Shareholders' Equity
3,557
12,865
16,404
15,499
15,281

About Mallinckrodt

View Profile
Address
3 Lotus Park
Staines-Upon-Thames Surrey TW18 3AG
United Kingdom
Employees -
Website http://mallinckrodt.com
Updated 07/08/2019
Mallinckrodt Plc operates as a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments.